ORIC:NASDAQ, ORIC Pharmaceuticals, Inc.

ORIC stock overview

ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ) closed at $7.36 on November 20, 2026, down 4.42% on the day. The stock trades 49.9% below its 52-week high of $14.68 and 1.8% above its 52-week low of $7.23. Over the past year, it lost 36.7%. ORIC Pharmaceuticals, Inc. is part of the Health Care sector.

Key figures

Price
$7.36
Day change
-4.42%
Volume
1,455,496
Average volume
1,579,345
Market cap
764M+
52-week range
$7.23 – $14.68
50-day average
$11.17
200-day average
$10.93

Price action over the past year

In 252 trading sessions since November 20, 2025, ORIC closed higher on 117 days (46%). Its best day was August 4, 2026 (+27.08%) and its worst was April 1, 2026 (-41.00%). The stock moved 10% or more in a single session 13 times.

Recent signals

ORIC news

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101 and ORIC-533.

Similar stocks

Find more stocks like ORIC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.